The Core Sequence of PIF Competes for Insulin/Amyloid β In Insulin Degrading Enzyme: Potential Treatment for Alzheimer’s Disease

Oncotarget - United States
doi 10.18632/oncotarget.26057
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Insulin-Degrading Enzyme in Brain Microvessels

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Nitric Oxide Inhibits Insulin-Degrading Enzyme Activity and Function Through S-Nitrosylation

Biochemical Pharmacology
BiochemistryPharmacology
2009English

Biochemical Characteristics of an Initial Degradation Product of Insulin by Insulin-Degrading Enzyme

Folia Endocrinologica Japonica
1988English

MiR-124 Acts as a Target for Alzheimer’s Disease by Regulating BACE1

Oncotarget
Oncology
2017English

Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance

PLoS ONE
Multidisciplinary
2011English

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

Archives of Neurology
2012English

Liposome Delivery Systems for the Treatment of Alzheimer’s Disease

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Insights Into Substrate Unfolding and Allosteric Regulation of Insulin Degrading Enzyme

Biophysical Journal
Biophysics
2017English

An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy